Mission Street and BGO to house Nucleome Therapeutics at Inventa (GB)

Mission Street and BGO to house Nucleome Therapeutics at Inventa (GB)

Mission Street and BGO have together in partnership signed leading biotechnology company Nucleome Therapeutics (Nucleome) as a landmark tenant at central Oxford’s first purpose-built commercial science scheme. The Nucleome will occupy c. 1,858m2 of fitted labs and offices in the 6,039m2 building. 

 

Inventa is the first commercial science scheme to be delivered in Oxford’s West End, the only innovation district within walking distance of Oxford train station and the city centre. The West End has a long-term pipeline of over 185,806m2 of commercial and academic buildings and will play a crucial role in realizing Oxford’s ambitions to become a global top three innovation cluster by 2040. 

 

Mission Street secured planning consent in December 2023 for the West End’s second phase, known as Fabrica. Construction for the 17,001m2, 5-storey, new-build scheme is due to commence in September this year. The two schemes, which have been a catalyst for change in the micro-location highlight both Mission Street and BGO’s strong conviction for well-connected, amenity-rich innovation clusters. Together, both firms have a pipeline of approximately 139,354m2 in such locations in Oxford, Cambridge, and Bristol.

 

Artem Korolev, founder and CEO of Mission Street, said: “Following extensive collaboration between our teams in designing and delivering Nucleome’s facility, we are excited to welcome them to Inventa for the next chapter of their growth.  We look forward to building a long-term partnership with them and delivering a world class urban innovation district across Inventa, Fabrica and the wider West End.” 

 

Stephen Harrison, Chief Scientific Officer of Nucleome Therapeutics, said: “Nucleome’s expansion, driven by the significant progress in identifying new drug candidates, has resulted in a need for larger office and lab space. We chose Inventa because of its central location, and Mission Street’s reputation for designing buildings that thoroughly accommodate the needs of life science companies.  We are looking forward to being part of this exciting new science and innovation hub in central Oxford.” 

 

CBRE and Bidwells advised on the leasing. 

 

Image provided by Monfort.

 

Europe Real Estate — an overview of real estate developments in European countries.

Related News